We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $618B
1-Year Est. Return 30.34%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.82%
2 Technology 2.79%
3 Financials 2.26%
4 Consumer Discretionary 1.92%
5 Industrials 1.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NEUE
14176
PUT
DELISTED
NeueHealth
NEUE
-375
Closed -$58K
ARQ icon
14177
Arq
ARQ
$99.6M
-42,107
Closed -$262K
ARQ icon
14178
PUT
Arq
ARQ
$99.6M
-20,900
Closed -$130K
BRLS icon
14179
Borealis Foods
BRLS
$17.2M
-603,646
Closed -$6.03M
BRLSW icon
14180
Borealis Foods Inc Warrant
BRLSW
-600,000
Closed -$139K
ABTC
14181
American Bitcoin Corp
ABTC
$533M
-1
Closed -$17.2K
ABTC
14182
PUT
American Bitcoin Corp
ABTC
$533M
-1
Closed -$42K
CEROW
14183
DELISTED
CERo Therapeutics Warrants
CEROW
-375,000
Closed -$71K
CERO
14184
DELISTED
CERo Therapeutics
CERO
-375
Closed -$7.5M
TVGN icon
14185
Tevogen Inc. Common Stock
TVGN
$27.7M
-5,001
Closed -$2.5M
ASTH icon
14186
Astrana Health
ASTH
$1.87B
-14,360
Closed -$546K
FFLC icon
14187
Fidelity Fundamental Large Cap Core ETF
FFLC
$1.24B
-19,616
Closed -$598K
FFLG icon
14188
Fidelity Fundamental Large Cap Growth ETF
FFLG
$625M
-14,256
Closed -$256K
TBRG
14189
PUT
DELISTED
TruBridge
TBRG
-9,100
Closed -$314K
GCTS
14190
GCT Semiconductor Holding
GCTS
$197M
-600,000
Closed -$5.96M
GCTS.WS
14191
GCT Semiconductor Holding Warrants
GCTS.WS
$18.7M
-430,536
Closed -$167K
BWIN
14192
CALL
Baldwin Insurance Group
BWIN
$2.99B
-43,700
Closed -$1.17M
INCE
14193
Franklin Income Equity Focus ETF
INCE
$279M
-40,156
Closed -$1.97M
ATYR
14194
aTyr Pharma
ATYR
$54.2M
-159,921
Closed -$578K
CMBT
14195
CMB.TECH NV
CMBT
$4.92B
-82,909
Closed -$997K
UFOX
14196
PUT
Defiance Space and Connective Tech ETF
UFOX
$922M
-5,400
Closed -$203K
QCLS
14197
CALL
Q/C Technologies Inc
QCLS
$22.5M
-10
Closed -$140K
FLDDW
14198
Fold Holdings Warrant
FLDDW
$948K
-261,294
Closed -$111K
FLD
14199
Fold Holdings
FLD
$26.1M
-532,400
Closed -$5.2M
NBIS
14200
PUT
Nebius Group N.V.
NBIS
$69.3B
-241,600
Closed -$1.66M

Similar funds

Ken Griffin's Q2 2022 Portfolio in Review

As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.